Recombinant, patient-derived FVIII-neutralising antibodies: a platform for research, product testing, and ex vivo modelling of haemophilia A

Posted by | Jul 31, 2019 | |

Carmen H Coxon1, Xinren Yu2, Scott Diamond2 Laura Diaz-Sáez3, James Beavis4, Andrew Riches1,...

Read More